In the rapidly evolving landscape of biotherapeutics, the quest for more efficient, stable, and penetrative molecules has led researchers away from traditional monoclonal antibodies (mAbs) toward a more compact powerhouse: the single-domain antibody (sdAb), often referred to as a VHH or Nanobody®.
While traditional IgG antibodies have revolutionized medicine, their large size...
Spanish 
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek